Introduction
The United States leads the world in biomedical research, new technologies, and novel therapeutics. 1 Thus, it's not surprising that, for select procedures and highly specialized care, the United States is a premier destination for international patients. Major medical centers increasingly view medical tourism as a potentially lucrative market to offset domestic cuts in reimbursement. 2 For patients with severe organ damage, transplantation offers hope for long-term survival and improved quality of life. Unfortunately, access to transplantation remains limited.
As of September 14, 2016 , 77,277 patients were actively listed for transplantation in the United States; an estimated 22 people die each day awaiting transplantation. 3 For many international patients, however, transplantation is not an option because of the lack of transplant services or donor organs locally. It's not surprising then that some wealthy patients without adequate domestic access would leverage their resources to obtain lifesaving transplantation abroad. 4 The National Organ Organ transplantation is perhaps the most explicit example of health care rationing in the United States. 6 Transplant centers strive to maximize utility of this scarce resource by limiting this therapeutic option to highly selected patients deemed to be likely to derive benefit. Candidates typically have reduced life expectancy, preserved rehabilitation potential, access to a transplant center, and adequate socioeconomic resources. Despite restricting transplantation to this small group, waitlist mortality remains substantial and would be dramatically higher if access were broadened. 7 For example, in 2014, only 1949 lung transplants were performed in the United States. 7 In contrast, chronic respiratory diseases, the third leading cause of death in the United States, accounted for almost 150,000 deaths in 2014 and more than 3 million deaths worldwide. 8, 9 Rationing of donor organs has largely been achieved through the development of center-specific patient selection criteria and national organ allocation criteria. Although there has been extensive public discourse and subsequent development of transparent regulation of organ allocation based on fundamental principles of medical ethics, other important determinants of transplant access have not been rigorously scrutinized. One example of inequity is the negative impact of lower socioeconomic status on a patient's candidacy for placement on the transplant waiting list. [10] [11] [12] [13] This is particularly troubling because all communities, including the poor, are encouraged to donate organs. Although suboptimal transplant outcome may be associated with reduced socioeconomic status and thus at face value appear to be an appropriate criteria for excluding some patients from the waiting list, very little responsibility is placed on the transplant center or government social services to develop approaches to support safer transplantation in this population.
It's clear that the severe organ shortage greatly reduces the opportunity for US citizens and residents to obtain lifesaving transplant procedures. In addition, access for poor patients is further limited. At present, there is no established mechanism for donors from other countries to contribute to the US donor pool. Without this reciprocity, transplantation of international patients unjustly punishes domestic patients and promotes health inequity for our citizens and residents.
One challenging issue that needs to be resolved is that unauthorized immigrants contribute to the national organ donor pool (up to 3.3% of donors), but are generally unable to receive transplant services. 5 This dilemma, however, does not diminish the merits of limiting transplantation to US citizens and residents, but instead focuses attention on other complex political, ethical, and legal controversies regarding barriers for unauthorized immigrants to obtaining legal status.
Impact on Organ Donation
In the United States and many countries around the world, the altruistic motivation for organ donation is exclusively emphasized. Organs are given freely and without any expectation of direct personal benefit for the individual or family members. Financial or other material incentives for organ donation are prohibited.
14 Although altruism may be simply defined as a selfless act that benefits another, it has not been established if Americans prefer restrictions on who benefits from this altruistic act. In fact, some bioethicists have suggested that solidarity, a form of altruism restricted to a group with shared identity (eg, citizenship/residency status), may be a more influential motivational factor. 15 Although restricting donation based on solidarity to race, religion, sex, or sexual orientation would be unethical and is prohibited, restrictions based on citizenship or residency is consistent with the social contract between a government and its citizens/ residents.
Published data, limited to 1 survey of 1049 adults, suggests that Americans have significant concerns about international patients travelling to the United States for transplant. 16 Thirty percent indicated that this practice should not be allowed and 38% responded that that they would be less inclined to donate if they were made aware that this practice occurs. 16 Societal support for our altruistic, voluntary system requires trust that organs will be allocated in a just, fair, and equitable manner. 17 Increased public awareness that wealthy patients from abroad are being transplanted in the United States despite domestic organ shortages, high waitlist mortality, and limited access for poor patients will likely further undermine trust and be detrimental to organ donation.
Deterring Transplant Tourism
The term transplant tourism refers generally to the practice of patients (usually wealthy) from 1 country travelling to another for transplantation. 4 Numerous bioethical questions have been raised about this practice. Horrific stories related to organ trafficking have been well documented and involve coercion, exploitation, and abuse of organ donors. Concern that commoditization of organs diminishes value of human life has also been raised. 18 Transplant tourism may also compromise a country's ability to provide transplant services to its own population. In response to these dangers, the World Health Organization and professional transplant societies have forcefully recommended that countries aggressively implement measures to prevent organ trafficking and transplant tourism. 19 In light of these compelling moral, ethical, and legal reasons to discourage all people, including Americans, from engaging in transplant tourism, we must be consistent and not allow noncitizens and residents access to donor organs in the United States.
Conclusion
The current state of transplantation in the United States is characterized by severe donor organ shortage, significant waitlist mortality, and limited access for our population because of medical and socioeconomic criteria. At present, there is no system for reciprocity in which other countries can contribute to the organ donor pool in the United States. Thus, transplantation of non-US citizens and residents enhances health inequity for our population. Public perception of wealthy individuals from other countries travelling to the United States for transplantation may further undermine trust and negatively impact willingness to donate, thereby potentially further exacerbating the organ shortage. For these reasons, international patients should not be chestjournal.org offered transplantation of organs from deceased donors in the United States.
